GH secretagogues
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
Prakash A, Goa KL. · BioDrugs · 1999
PMID: 18031173 · DOI: 10.2165/00063030-199912020-00009
Summary
Pharmacologic review of sermorelin (GHRH 1-29) covering diagnostic provocative testing and pediatric idiopathic GH deficiency literature. Synthesizes clinical pharmacokinetics and growth response endpoints.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
Compounds referenced in this study
- View product →Sermorelin29-residue GHRH analog. Studied as a research probe of the somatotropic axis.
Guides covering this compound
More GH secretagogues citations
- Ipamorelin, the first selective growth hormone secretagogueEur J Endocrinol · 1998
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsGrowth Horm IGF Res · 1999
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsJ Clin Endocrinol Metab · 2006